{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:24:52Z","timestamp":1786980292019,"version":"build-2736575974"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:00:00Z","timestamp":1641859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Studies in 1983 and 1993 identified and ranked symptoms experienced by cancer patients receiving chemotherapy. We repeated the studies to obtain updated information on patient perceptions of chemotherapy-associated symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and methods<\/jats:title>\n                    <jats:p>A cross-sectional interview and patient-reported outcome questionnaires were administered to out-patients receiving chemotherapy. Patients selected from 124 cards to identify and rank the severity of physical and non-physical symptoms they had experienced and attributed to chemotherapy (primary endpoint). The patient\u2019s medical oncologist and primary chemotherapy nurse were invited to rank the five symptoms they believed the patient would rank as their most severe. We analysed the association of symptoms and their severity with patient demographics, chemotherapy regimen, and patient-reported outcomes. Results were compared to the earlier studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 302 patients completed the interview: median age 58 years (range 17\u201385); 56% female; main tumour types colorectal 81 (27%), breast 67 (22%), lung 49 (16%); 45% treated with curative intent. Most common symptoms (reported by &gt;50%) were: alopecia, general weakness, effects on family\/partner, loss of taste, nausea, fatigue, difficulty sleeping, effects on work\/home duties, and having to put life on hold. The most severe symptoms (ranked by &gt;15% in top five) were: concern about effects on family\/partner, nausea, fear of the future, fatigue, not knowing what will happen, putting my life on hold, and general weakness. Perceptions of doctors and nurses of patients\u2019 symptom severity closely matched patients\u2019 rankings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Compared to earlier studies, there was an increase in non-physical concerns such as effects on family and future, and a decrease in physical symptoms, particularly vomiting, but nausea, fatigue and general weakness remained bothersome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Highlights<\/jats:title>\n                    <jats:p>\u2022 Symptoms related to chemotherapy have changed over time, likely due to less toxic regimens and improvements in supportive care.<\/jats:p>\n                    <jats:p>\u2022 Effects on family\/partner, fear of the future, not knowing what will happen, and \u201clife on hold\u201d were major issues for patients.<\/jats:p>\n                    <jats:p>\u2022 Vomiting has decreased but nausea, fatigue and general weakness remain common symptoms for chemotherapy patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00520-022-06804-1","type":"journal-article","created":{"date-parts":[[2022,1,11]],"date-time":"2022-01-11T00:02:41Z","timestamp":1641859361000},"page":"3503-3512","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["On the receiving end: have patient perceptions of the side-effects of cancer chemotherapy changed since the twentieth century?"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5739-5790","authenticated-orcid":false,"given":"Janette L.","family":"Vardy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Liew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Warby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Elder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itay","family":"Keshet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhonda","family":"Devine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calina","family":"Ouliaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corrinne","family":"Renton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin H. N.","family":"Tattersall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haryana M.","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,11]]},"reference":[{"key":"6804_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/0277-5379(83)90418-2","volume":"19","author":"A Coates","year":"1983","unstructured":"Coates A, Abraham S, Kaye SB et al (1983) On the receiving end\u2014patient perception of the side-effects of cancer chemotherapy. Eur J Cancer Clin Oncol 19:203\u2013208","journal-title":"Eur J Cancer Clin Oncol"},{"key":"6804_CR2","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/oxfordjournals.annonc.a010548","volume":"7","author":"AM Griffin","year":"1996","unstructured":"Griffin AM, Butow PN, Coates AS et al (1996) On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993. Ann Oncol 7:189\u2013195","journal-title":"Ann Oncol"},{"key":"6804_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/cncr.10630","volume":"95","author":"N Carelle","year":"2002","unstructured":"Carelle N, Piotto E, Bellanger A et al (2002) Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 95:155\u2013163","journal-title":"Cancer"},{"key":"6804_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/cam4.1915","volume":"8","author":"Y Tran","year":"2019","unstructured":"Tran Y, Lamprell K, Nic Giolla Easpaig B et al (2019) What information do patients want across their cancer journeys? A network analysis of cancer patients' information needs. Cancer Med 8:155\u2013164","journal-title":"Cancer Med"},{"key":"6804_CR5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1369-7625.2009.00587.x","volume":"13","author":"S Singh","year":"2010","unstructured":"Singh S, Butow P, Charles M, Tattersall MH (2010) Shared decision making in oncology: assessing oncologist behaviour in consultations in which adjuvant therapy is considered after primary surgical treatment. Health Expect 13:244\u2013257","journal-title":"Health Expect"},{"key":"6804_CR6","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1056\/NEJMp1600894","volume":"374","author":"DR Lowy","year":"2016","unstructured":"Lowy DR, Collins FS (2016) Aiming high\u2014changing the trajectory for cancer. N Engl J Med 374:1901\u20131904","journal-title":"N Engl J Med"},{"key":"6804_CR7","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"6804_CR8","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1038\/sj.bjc.6602836","volume":"93","author":"B Colinet","year":"2005","unstructured":"Colinet B, Jacot W, Bertrand D et al (2005) A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index. Br J Cancer 93:1098\u20131105","journal-title":"Br J Cancer"},{"key":"6804_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1200\/JCO.1993.11.3.570","volume":"11","author":"D Cella","year":"1993","unstructured":"Cella D, Tulsky DS, Gray G et al (1993) The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11:10","journal-title":"J Clin Oncol"},{"key":"6804_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0885-3924(96)00274-6","volume":"13","author":"SB Yellen","year":"1997","unstructured":"Yellen SB, Cella DF, Webster K et al (1997) Measuring fatigue and other anemia-related symptoms with the Functional Assessment of Cancer Therapy (FACT) measurement system. J Pain Symptom Manag 13:63\u201374","journal-title":"J Pain Symptom Manag"},{"key":"6804_CR11","unstructured":"Goldberg DP. A user's guide to the General Health Questionnaire. In NFER-Nelson 1991"},{"key":"6804_CR12","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3109\/07853890109002087","volume":"33","author":"R Rabin","year":"2001","unstructured":"Rabin R, de Charro F (2001) EQ-5D: a measure of health status from the EuroQol Group. Ann Med 33:337\u2013343","journal-title":"Ann Med"},{"key":"6804_CR13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1634\/theoncologist.2014-0438","volume":"20","author":"TL Ng","year":"2015","unstructured":"Ng TL, Hutton B, Clemons M (2015) Chemotherapy-induced nausea and vomiting: time for more emphasis on nausea? Oncologist 20:576\u2013583","journal-title":"Oncologist"},{"key":"6804_CR14","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1093\/annonc\/mdw252","volume":"27","author":"JL Vardy","year":"2016","unstructured":"Vardy JL, Dhillon HM, Pond GR et al (2016) Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study. Ann Oncol 27:1761\u20131767","journal-title":"Ann Oncol"},{"key":"6804_CR15","doi-asserted-by":"publisher","first-page":"3833","DOI":"10.1002\/cncr.26226","volume":"118","author":"MM Goedendorp","year":"2012","unstructured":"Goedendorp MM, Andrykowski MA, Donovan KA et al (2012) Prolonged impact of chemotherapy on fatigue in breast cancer survivors: a longitudinal comparison with radiotherapy-treated breast cancer survivors and noncancer controls. Cancer 118:3833\u20133841","journal-title":"Cancer"},{"key":"6804_CR16","doi-asserted-by":"publisher","first-page":"5740","DOI":"10.1002\/cncr.25294","volume":"116","author":"MA Andrykowski","year":"2010","unstructured":"Andrykowski MA, Donovan KA, Laronga C, Jacobsen PB (2010) Prevalence, predictors, and characteristics of off-treatment fatigue in breast cancer survivors. Cancer 116:5740\u20135748","journal-title":"Cancer"},{"key":"6804_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ejca.2003.10.008","volume":"40","author":"CG Koedoot","year":"2004","unstructured":"Koedoot CG, Oort FJ, de Haan RJ et al (2004) The content and amount of information given by medical oncologists when telling patients with advanced cancer what their treatment options are. Palliative chemotherapy and watchful-waiting. Eur J Cancer 40:225\u2013235","journal-title":"Eur J Cancer"},{"key":"6804_CR18","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG et al (2016) Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. J Clin Oncol 34:557\u2013565","journal-title":"J Clin Oncol"},{"key":"6804_CR19","doi-asserted-by":"publisher","first-page":"3027","DOI":"10.1001\/jama.288.23.3027","volume":"288","author":"SB Detmar","year":"2002","unstructured":"Detmar SB, Muller MJ, Schornagel JH et al (2002) Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial. JAMA 288:3027\u20133034","journal-title":"JAMA"},{"key":"6804_CR20","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1001\/archinternmed.2009.179","volume":"169","author":"KE Hoffman","year":"2009","unstructured":"Hoffman KE, McCarthy EP, Recklitis CJ, Ng AK (2009) Psychological distress in long-term survivors of adult-onset cancer: results from a national survey. Arch Intern Med 169:1274\u20131281","journal-title":"Arch Intern Med"},{"key":"6804_CR21","first-page":"32","volume":"32","author":"P Butow","year":"2018","unstructured":"Butow P, Sharpe L, Thewes B et al (2018) Fear of cancer recurrence: a practical guide for clinicians. Oncology (Williston Park) 32:32\u201338","journal-title":"Oncology (Williston Park)"},{"key":"6804_CR22","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1038\/bjc.1997.610","volume":"76","author":"G Macquart-Moulin","year":"1997","unstructured":"Macquart-Moulin G, Viens P, Bouscary ML et al (1997) Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care. Br J Cancer 76:1640\u20131645","journal-title":"Br J Cancer"},{"key":"6804_CR23","doi-asserted-by":"publisher","first-page":"3485","DOI":"10.1200\/JCO.2004.03.025","volume":"22","author":"EK Fromme","year":"2004","unstructured":"Fromme EK, Eilers KM, Mori M et al (2004) How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30. J Clin Oncol 22:3485\u20133490","journal-title":"J Clin Oncol"},{"key":"6804_CR24","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/S1470-2045(06)70910-X","volume":"7","author":"E Basch","year":"2006","unstructured":"Basch E, Iasonos A, McDonough T et al (2006) Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 7:903\u2013909","journal-title":"Lancet Oncol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-06804-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-022-06804-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-022-06804-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T12:05:16Z","timestamp":1700049916000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-022-06804-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,11]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["6804"],"URL":"https:\/\/doi.org\/10.1007\/s00520-022-06804-1","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,11]]},"assertion":[{"value":"12 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was granted by each hospital institutional review board prior to commencement. Written informed consent was obtained from each subject.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}